Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ERI1 Exoribonuclease Family Member 2 (EXOD1) (N-Term) Peptid

EXOD1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN976514

Kurzübersicht für ERI1 Exoribonuclease Family Member 2 (EXOD1) (N-Term) Peptid (ABIN976514)

Target

ERI2 (EXOD1) (ERI1 Exoribonuclease Family Member 2 (EXOD1))

Spezies

Human

Quelle

  • 3
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequenz

    GQIDSEFQAY VQPQEHPILS EFCMELTGIK QAQVDEGVPL KICLSQFCKW

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-EXOD1 Antibody(ARP52508_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    ERI2 (EXOD1) (ERI1 Exoribonuclease Family Member 2 (EXOD1))

    Hintergrund

    EXOD1 belongs to the EXOD1 family. It contains 1 exonuclease domain. EXOD1 is a member of a new subclass of exonucleases called the 3'hExo/ERI-1 subfamily of DEDDh nucleases.

    Alias Symbols: KIAA1504, MGC16943, EXOD1

    Protein Size: 328

    Molekulargewicht

    37 kDa

    Gen-ID

    112479

    NCBI Accession

    NM_080663, NP_542394

    UniProt

    A8K979
Sie sind hier:
Chat with us!